Jet Kant

908 total citations
22 papers, 662 citations indexed

About

Jet Kant is a scholar working on Infectious Diseases, Ecology, Evolution, Behavior and Systematics and Global and Planetary Change. According to data from OpenAlex, Jet Kant has authored 22 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 11 papers in Ecology, Evolution, Behavior and Systematics and 10 papers in Global and Planetary Change. Recurrent topics in Jet Kant's work include Viral Infections and Vectors (17 papers), Viral Infections and Outbreaks Research (11 papers) and Vector-Borne Animal Diseases (11 papers). Jet Kant is often cited by papers focused on Viral Infections and Vectors (17 papers), Viral Infections and Outbreaks Research (11 papers) and Vector-Borne Animal Diseases (11 papers). Jet Kant collaborates with scholars based in Netherlands, United States and France. Jet Kant's co-authors include Jeroen Kortekaas, R.J.M. Moormann, Lucien van Keulen, Paul J. Wichgers Schreur, A.F.G. Antonis, Rianka P. M. Vloet, S.M. de Boer, Nadia Oreshkova, Berend‐Jan Bosch and S M Hubbard and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Jet Kant

22 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jet Kant Netherlands 17 511 294 159 90 81 22 662
Ivanov Ap Russia 14 460 0.9× 104 0.4× 171 1.1× 57 0.6× 38 0.5× 60 619
Åke Lundkvist Sweden 8 235 0.5× 74 0.3× 119 0.7× 83 0.9× 21 0.3× 8 315
Claudia Filippone France 16 429 0.8× 95 0.3× 37 0.2× 43 0.5× 13 0.2× 30 676
Ye Sun China 13 291 0.6× 91 0.3× 9 0.1× 126 1.4× 18 0.2× 32 625
Laurent Guillemot France 15 276 0.5× 79 0.3× 56 0.4× 63 0.7× 7 0.1× 21 628
Jonas Schmidt Germany 9 263 0.5× 88 0.3× 161 1.0× 49 0.5× 6 0.1× 24 342
Eugenio Ramı́rez Chile 17 303 0.6× 155 0.5× 123 0.8× 80 0.9× 5 0.1× 56 717
Rui Qi China 14 273 0.5× 55 0.2× 43 0.3× 67 0.7× 16 0.2× 47 537
Zoe S. White United States 13 169 0.3× 27 0.1× 37 0.2× 54 0.6× 112 1.4× 23 726
Elif Akdoğan Türkiye 7 286 0.6× 149 0.5× 78 0.5× 150 1.7× 3 0.0× 16 372

Countries citing papers authored by Jet Kant

Since Specialization
Citations

This map shows the geographic impact of Jet Kant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jet Kant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jet Kant more than expected).

Fields of papers citing papers by Jet Kant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jet Kant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jet Kant. The network helps show where Jet Kant may publish in the future.

Co-authorship network of co-authors of Jet Kant

This figure shows the co-authorship network connecting the top 25 collaborators of Jet Kant. A scholar is included among the top collaborators of Jet Kant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jet Kant. Jet Kant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schreur, Paul J. Wichgers, Petra Mooij, Gerrit Koopman, et al.. (2022). Safety and immunogenicity of four-segmented Rift Valley fever virus in the common marmoset. npj Vaccines. 7(1). 54–54. 11 indexed citations
2.
Kuzmyn, Andriy R., et al.. (2022). Antiviral Polymer Brushes by Visible-Light-Induced, Oxygen-Tolerant Covalent Surface Coating. ACS Omega. 7(43). 38371–38379. 11 indexed citations
3.
Schreur, Paul J. Wichgers, Mirriam G. J. Tacken, Markus Keller, et al.. (2021). Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus. Vaccines. 9(3). 301–301. 20 indexed citations
4.
Schreur, Paul J. Wichgers, Jet Kant, Sandra van de Water, et al.. (2021). A single vaccination with four-segmented Rift Valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes. npj Vaccines. 6(1). 8–8. 12 indexed citations
5.
Schreur, Paul J. Wichgers, Rianka P. M. Vloet, Jet Kant, et al.. (2021). Reproducing the Rift Valley fever virus mosquito-lamb-mosquito transmission cycle. Scientific Reports. 11(1). 1477–1477. 21 indexed citations
6.
Schreur, Paul J. Wichgers, Nadia Oreshkova, Lucien van Keulen, et al.. (2020). Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle. npj Vaccines. 5(1). 65–65. 21 indexed citations
7.
Schreur, Paul J. Wichgers, et al.. (2020). Rift Valley fever virus targets the maternal-foetal interface in ovine and human placentas. PLoS neglected tropical diseases. 14(1). e0007898–e0007898. 41 indexed citations
8.
Schreur, Paul J. Wichgers, Lucien van Keulen, Jet Kant, & Jeroen Kortekaas. (2017). Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy. Vaccine. 35(23). 3123–3128. 21 indexed citations
9.
Schreur, Paul J. Wichgers, Janusz T. Pawęska, Jet Kant, & Jeroen Kortekaas. (2017). A novel highly sensitive, rapid and safe Rift Valley fever virus neutralization test. Journal of Virological Methods. 248. 26–30. 14 indexed citations
10.
Schreur, Paul J. Wichgers, Lucien van Keulen, Jet Kant, et al.. (2016). Co-housing of Rift Valley Fever Virus Infected Lambs with Immunocompetent or Immunosuppressed Lambs Does Not Result in Virus Transmission. Frontiers in Microbiology. 7. 17 indexed citations
11.
Schreur, Paul J. Wichgers, Jet Kant, Lucien van Keulen, R.J.M. Moormann, & Jeroen Kortekaas. (2015). Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination. Vaccine. 33(12). 1459–1464. 25 indexed citations
12.
Kortekaas, Jeroen, Nadia Oreshkova, Lucien van Keulen, et al.. (2014). Comparative efficacy of two next-generation Rift Valley fever vaccines. Vaccine. 32(39). 4901–4908. 24 indexed citations
13.
Antonis, A.F.G., Jeroen Kortekaas, Jet Kant, et al.. (2013). Vertical Transmission of Rift Valley Fever Virus Without Detectable Maternal Viremia. Vector-Borne and Zoonotic Diseases. 13(8). 601–606. 33 indexed citations
14.
Oreshkova, Nadia, Lucien van Keulen, Jet Kant, R.J.M. Moormann, & Jeroen Kortekaas. (2013). A Single Vaccination with an Improved Nonspreading Rift Valley Fever Virus Vaccine Provides Sterile Immunity in Lambs. PLoS ONE. 8(10). e77461–e77461. 31 indexed citations
15.
Kortekaas, Jeroen, Jet Kant, Rianka P. M. Vloet, et al.. (2012). European ring trial to evaluate ELISAs for the diagnosis of infection with Rift Valley fever virus. Journal of Virological Methods. 187(1). 177–181. 51 indexed citations
16.
Kortekaas, Jeroen, A.F.G. Antonis, Jet Kant, et al.. (2012). Efficacy of three candidate Rift Valley fever vaccines in sheep. Vaccine. 30(23). 3423–3429. 60 indexed citations
17.
Kortekaas, Jeroen, S.M. de Boer, Jet Kant, et al.. (2010). Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine. 28(27). 4394–4401. 59 indexed citations
18.
Boer, S.M. de, Jeroen Kortekaas, A.F.G. Antonis, et al.. (2010). Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge. Vaccine. 28(11). 2330–2339. 58 indexed citations
19.
Hsu, Shu‐Hao, et al.. (1992). Demonstration of passenger leukocytes in a case of Epstein-Barr virus posttransplant lymphoproliferative disorder using restriction fragment length polymorphism analysis.. PubMed. 116(3). 249–52. 7 indexed citations
20.
Kant, Jet, et al.. (1986). The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.. Journal of Clinical Oncology. 4(3). 284–294. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivanov Ap Breakdown of academic impact, for papers by Åke Lundkvist Breakdown of academic impact, for papers by Claudia Filippone Breakdown of academic impact, for papers by Ye Sun Breakdown of academic impact, for papers by Laurent Guillemot Breakdown of academic impact, for papers by Jonas Schmidt Breakdown of academic impact, for papers by Eugenio Ramı́rez Breakdown of academic impact, for papers by Rui Qi Breakdown of academic impact, for papers by Zoe S. White Breakdown of academic impact, for papers by Elif Akdoğan
Rankless by CCL
2026